Clinical Trials

NCT05294991 | ACTIVE_NOT_RECRUITING | NA

276 participants

Wellness App for Sleep Disturbance in Hematological Cancer Patients

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2023-02-20

Completion:

2026-12-20

Conditions

• Cancer
• Sleep Disturbance
• Anxiety
• Depression
• Inflammation
• Fatigue

Interventions

• BEHAVIORAL

No Results Yet

NCT05267340 | COMPLETED | NA

120 participants

Neural Mechanisms of Meditation Training in Healthy and Depressed Adolescents: An MRI Connectome Study PART 2

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2023-02-08

Completion:

2025-12-11

Conditions

• Depression Mild
• Depression Moderate
• Depression, Teen

Interventions

• BEHAVIORAL

No Results Yet

NCT05258305 | COMPLETED | NA

200 participants

AuraClens™ System in Processing of Lipoaspirate for Autologous Fat Grafting to the Breast

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2022-05-05

Completion:

2025-01-08

Conditions

• Breast Fat Grafting Retention

Interventions

• DEVICE

Results Available

NCT05256537 | ACTIVE_NOT_RECRUITING | PHASE2

60 participants

Fludarabine and Total Body Irradiation 800 Centigray (cGy) or 1125 cGy For Allogeneic Stem Cell Transplant Using Graft Versus Host Disease Prophylaxis With Post-Transplant Cyclophosphamide and Tacrolimus, Without Mycophenolate Mofetil

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2022-04-26

Completion:

2024-09-20

Conditions

• Hematologic Neoplasms

Interventions

• OTHER

No Results Yet

NCT05249556 | NOT_YET_RECRUITING | PHASE3

20 participants

Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Old

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2027-03-31

Completion:

2029-12-31

Conditions

• CDKL5 Deficiency Disorder

Interventions

• DRUG

No Results Yet

NCT05235074 | COMPLETED | PHASE1/PHASE2

40 participants

OH2 Oncolytic Viral Therapy in Central Nervous System Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2021-11-16

Completion:

2026-07-23

Conditions

• Central Nervous System Tumors

Interventions

• BIOLOGICAL

No Results Yet

NCT05215106 | ACTIVE_NOT_RECRUITING | PHASE2

200 participants

Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2021-12-06

Completion:

2026-08-15

Conditions

• Early Small (cT1N0) Triple Negative Breast Cancer

Interventions

• DRUG

No Results Yet

NCT05210803 | ENROLLING_BY_INVITATION | PHASE2

116 participants

Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2021-12-20

Completion:

2031-07-31

Conditions

• Neovascular Age-Related Macular Degeneration (nAMD)

Interventions

• DRUG

No Results Yet

NCT05199441 | COMPLETED | PHASE4

226 participants

Efficacy of Galeo® in Patients With Postprandial Distress Syndrome Subtype in Functional Dyspepsia

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2022-02-25

Completion:

2023-07-05

Conditions

• Dyspepsia

Interventions

• DRUG

No Results Yet

NCT05176483 | RECRUITING | PHASE1

1394 participants

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2021-12-14

Completion:

2027-01-31

Conditions

• Renal Cell Carcinoma (RCC)
• Metastatic Castration-Resistant Prostate Cancer (mCRPC)
• Urothelial Carcinoma (UC)
• Solid Tumor
• Hepatocellular Carcinoma (HCC)
• Non-small Cell Lung Cancer (NSCLC)
• Colorectal Cancer (CRC)
• Head and Neck Squamous Cell Carcinoma (HNSCC)
• Clear Cell Renal Cell Carcinoma (ccRCC)
• Non-Clear Cell Renal Cell Carcinoma (nccRCC)
• Drug-Drug Interaction (DDI)

Interventions

• DRUG

No Results Yet

NCT05171647 | ACTIVE_NOT_RECRUITING | PHASE3

208 participants

A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2022-04-25

Completion:

2025-02-17

Conditions

• Non-Hodgkin Lymphoma

Interventions

• DRUG

Results Available

NCT05170204 | ACTIVE_NOT_RECRUITING | PHASE3

68 participants

A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2022-11-01

Completion:

2030-06-16

Conditions

• Non-Small Cell Lung Cancer

Interventions

• DRUG

No Results Yet

NCT05144542 | ACTIVE_NOT_RECRUITING | NA

135 participants

Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2022-03-07

Completion:

2025-10-17

Conditions

• Lung Carcinoma

Interventions

• DRUG

Results Available

NCT05134454 | ACTIVE_NOT_RECRUITING | NA

3300 participants

Atrial Fibrillation Screening Post Ischemic Cerebrovascular Events

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2022-01-20

Completion:

2025-12-31

Conditions

• Ischemic Stroke
• TIA

Interventions

• DIAGNOSTIC_TEST

No Results Yet

NCT05091424 | RECRUITING | PHASE1

332 participants

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2022-03-07

Completion:

2031-02-10

Conditions

• Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Interventions

• DRUG

No Results Yet

NCT05087745 | RECRUITING | EARLY_PHASE1

50 participants

A Clinical Study on TIL for the Treatment of Advanced Solid Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2021-12-10

Completion:

2027-12-10

Conditions

• Advanced Solid Tumor
• Tumor Infiltrating Lymphocytes
• Treatment Side Effects
• Effects of Immunotherapy

Interventions

• BIOLOGICAL

No Results Yet

NCT05086900 | COMPLETED

283 participants

Developing a PROM for Recurrent Urinary Tract Infection

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-05

Start Date:

2021-05-01

Completion:

2021-09-01

Conditions

• Urologic Diseases
• Patient Satisfaction
• Pain, Chronic
• Sexual Dysfunction

Interventions

• OTHER

Results Available

NCT05039619 | RECRUITING | PHASE2

40 participants

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2022-05-12

Completion:

2028-06-15

Conditions

• Lupus Nephritis

Interventions

• DRUG

No Results Yet

NCT05008848 | RECRUITING | PHASE3

600 participants

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2022-04-01

Completion:

2027-03-01

Conditions

• Cigarette Smoking-Related Carcinoma

Interventions

• BEHAVIORAL
• OTHER

No Results Yet

NCT04999761 | RECRUITING | PHASE1

917 participants

AB122 Platform Study

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2021-06-01

Completion:

2027-06-30

Conditions

• Advanced or Metastatic Solid Tumor
• Pancreatic Ductal Adenocarcinoma
• Colorectal Cancer
• Non-small Cell Lung Cancer
• Gastric Cancer
• Alveolar Soft Part Sarcoma
• Esophageal Cancer
• Head and Neck Cancer
• Biliary Tract Cancer

Interventions

• DRUG

No Results Yet

NCT04967833 | RECRUITING | EARLY_PHASE1

20 participants

A Study of GC101 TIL in Advanced Solid Tumors (TR)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2021-04-22

Completion:

2027-12-22

Conditions

• Advanced Solid Tumors

Interventions

• BIOLOGICAL

No Results Yet

NCT04960072 | RECRUITING | EARLY_PHASE1

50 participants

A Study of GC101 TIL in r/r Gastrointestinal Tumors (10hospital)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2021-06-30

Completion:

2027-12-30

Conditions

• Gastrointestinal Tumor

Interventions

• BIOLOGICAL

No Results Yet

NCT04943913 | RECRUITING | EARLY_PHASE1

50 participants

Study of GC101 TIL in Brain Glioma (Soochow2)

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2021-05-06

Completion:

2026-12-30

Conditions

• Glioma

Interventions

• BIOLOGICAL

No Results Yet

NCT04929236 | RECRUITING | PHASE3

30 participants

Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2023-10-01

Completion:

2028-12-31

Conditions

• Pediatric Chronic Inflammatory Demyelinating Polyneuropathy

Interventions

• DRUG

No Results Yet

NCT04923555 | COMPLETED | NA

33 participants

Analysis of the Postprandial Effects of a Vegetable Protein Mixture Rich in Arginine, Cysteine and Leucine on Endothelial Dysfunction and Inflammation at Low Noise in Elderly People With Cardiometabolic Risk

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2021-11-09

Completion:

2022-06-07

Conditions

• Metabolic Syndrome
• Predisposition to Cardiovascular Disease

Interventions

• BEHAVIORAL

No Results Yet

NCT04919122 | ACTIVE_NOT_RECRUITING

468 participants

Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-05

Start Date:

2022-04-01

Completion:

2026-12-31

Conditions

• Metastatic Renal Cell Carcinoma

No Results Yet

NCT04906096 | RECRUITING | PHASE2

25 participants

Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2021-06-01

Completion:

2026-12-01

Conditions

• Primary Central Nervous System Lymphoma
• Non-Hodgkin Lymphoma of Extranodal Site

Interventions

• DRUG

No Results Yet

NCT04900623 | RECRUITING | PHASE2

145 participants

Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2021-07-02

Completion:

2030-06-01

Conditions

• HPV-Associated Oropharyngeal Squamous Cell Carcinoma
• HPV Positive Oropharyngeal Squamous Cell Carcinoma
• HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Stage
• HPV-Related Squamous Cell Carcinoma
• Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
• Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
• Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
• Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
• Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
• Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
• HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Clinical Stage
• HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Pathologic Stage

Interventions

• DEVICE
• RADIATION
• DRUG

No Results Yet

NCT04892823 | RECRUITING

110 participants

Social Relationships and Accelerated Aging in Hematopoietic Cell Transplant Survivors

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-05

Start Date:

2021-05-18

Completion:

2027-07-16

Conditions

• Hematopoietic and Lymphoid Cell Neoplasm

Interventions

• PROCEDURE
• OTHER

No Results Yet

NCT04891640 | COMPLETED | PHASE4

164 participants

Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2021-11-11

Completion:

2026-06-01

Conditions

• Juvenile Spondyloarthritis

Interventions

• OTHER

No Results Yet

NCT04889911 | COMPLETED | NA

17 participants

Pilot RCT of Self-stigma Treatment for First Episode Psychosis

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2023-08-01

Completion:

2025-10-27

Conditions

• First Episode Psychosis
• Youth

Interventions

• OTHER
• BEHAVIORAL

No Results Yet

NCT04855305 | COMPLETED | PHASE2

47 participants

Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2021-11-12

Completion:

2025-06-11

Conditions

• Interstitial Lung Diseases

Interventions

• DRUG

Results Available

NCT04851288 | COMPLETED | PHASE2

112 participants

Mitochondrial-targeted Antioxidant Supplementation for Improving Age-related Vascular Dysfunction in Humans

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2021-04-02

Completion:

2025-12-01

Conditions

• Aging

Interventions

• DIETARY_SUPPLEMENT

No Results Yet

NCT04840563 | COMPLETED | NA

10 participants

Surface Refractive Index Shift of Kalifilcon A Compared With Dailies Total1 and Precision1 Lenses

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2021-04-07

Completion:

2021-04-15

Conditions

• Contact Lens Wear

Interventions

• DEVICE

Results Available

NCT04833790 | COMPLETED | NA

2451 participants

What Drives Poor Care for Child Diarrhea: A Standardized Patient Experiment

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2022-05-05

Completion:

2022-12-31

Conditions

• Child Diarrhea

Interventions

• BEHAVIORAL

Results Available

NCT04827862 | COMPLETED | PHASE2

6 participants

RADVAX™ for Relapsed/Refractory Non-Hodgkin Lymphoma: A Phase II Trial of Pembrolizumab + Low Dose Radiotherapy

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2022-07-01

Completion:

2026-05-01

Conditions

• Non Hodgkin Lymphoma

Interventions

• DRUG

No Results Yet

NCT04810871 | SUSPENDED | NA

40 participants

Surgical Resection of Latent Brain Tumors Prior to Recurrence

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2021-05-06

Completion:

2028-03-01

Conditions

• Brain Neoplasm

Interventions

• PROCEDURE

No Results Yet

NCT04802759 | RECRUITING | PHASE1/PHASE2

316 participants

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2021-06-22

Completion:

2029-05-30

Conditions

• Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer

Interventions

• DRUG

No Results Yet

NCT04794075 | RECRUITING | NA

300 participants

Therapeutic Education and Nursing Support Program for Supportive Care, in Patients Treated With Hormone Therapy for Non-metastatic Breast Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-08-05

Start Date:

2021-08-09

Completion:

2028-08-31

Conditions

• Neoplasm of Breast

Interventions

• OTHER

No Results Yet

NCT04788836 | COMPLETED

61 participants

How Altered Gut-Brain-Axis Influences Food Choices: Part 2 (BrainFood)

Study Type:

OBSERVATIONAL

Last Updated:

2026-08-05

Start Date:

2021-11-01

Completion:

2025-12-31

Conditions

• Food Preferences
• Obesity

Interventions

• OTHER

No Results Yet